The enigmatic helicase DHX9 as a candidate prognostic biomarker for resected pancreatic ductal adenocarcinoma

Overview of attention for article published in Frontiers in oncology, December 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 23,814 followers.

The enigmatic helicase DHX9 as a candidate prognostic biomarker for resected pancreatic ductal adenocarcinoma https://t.co/zzyC6lSqAz https://t.co/G78fbMaSRO

13 Dec 2022

Reply Repost Favourite

New research: The enigmatic helicase DHX9 as a candidate prognostic biomarker for resected pancreatic ductal adenocarcinoma: Background Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, and current therapies… https://t.c

13 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.